|Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder|
RM Bilder, RS Goldman, J Volavka, P Czobor, M Hoptman, B Sheitman, ...
American Journal of Psychiatry 159 (6), 1018-1028, 2002
|Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics|
JP Lindenmayer, P Czobor, J Volavka, L Citrome, B Sheitman, JP McEvoy, ...
American Journal of Psychiatry 160 (2), 290-296, 2003
|Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder|
J Volavka, P Czobor, B Sheitman, JP Lindenmayer, L Citrome, JP McEvoy, ...
American Journal of Psychiatry 159 (2), 255-262, 2002
|Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology|
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
|Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia|
RM Bilder, J Volavka, P ál Czobor, AK Malhotra, JL Kennedy, X Ni, ...
Biological psychiatry 52 (7), 701-707, 2002
|Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder|
MI Krakowski, P Czobor, L Citrome, N Bark, TB Cooper
Archives of General Psychiatry 63 (6), 622-629, 2006
|Antipsychotic-induced weight gain and therapeutic response: a differential association|
P Czobor, J Volavka, B Sheitman, JP Lindenmayer, L Citrome, J McEvoy, ...
Journal of clinical psychopharmacology 22 (3), 244-251, 2002
|Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia|
L Citrome, J Volavka, P Czobor, B Sheitman, JP Lindenmayer, J McEvoy, ...
Psychiatric Services 52 (11), 1510-1514, 2001
|Good publication practice for communicating company-sponsored medical research: GPP3|
WP Battisti, E Wager, L Baltzer, D Bridges, A Cairns, CI Carswell, ...
Annals of Internal Medicine 163 (6), 461-464, 2015
|Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol|
J Volavka, P Czobor, K Nolan, B Sheitman, JP Lindenmayer, L Citrome, ...
Journal of clinical psychopharmacology 24 (2), 225-228, 2004
|The use of long-acting injectable antipsychotics in schizophrenia: evaluating the evidence|
CU Correll, L Citrome, PM Haddad, J Lauriello, M Olfson, SM Calloway, ...
The Journal of clinical psychiatry 77 (suppl 3), 0-0, 2016
|Heterogeneity of violence in schizophrenia and implications for long‐term treatment|
J Volavka, L Citrome
International journal of clinical practice 62 (8), 1237-1245, 2008
|Pathways to aggression in schizophrenia affect results of treatment|
J Volavka, L Citrome
Schizophrenia bulletin 37 (5), 921-929, 2011
|Characteristics of assaultive behavior among psychiatric inpatients|
KA Nolan, P Czobor, BB Roy, MM Platt, CB Shope, LL Citrome, J Volavka
Psychiatric services 54 (7), 1012-1016, 2003
|Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response|
JP Lindenmayer, H Liu-Seifert, PM Kulkarni, BJ Kinon, V Stauffer, ...
The Journal of clinical psychiatry 70 (7), 11521, 2009
|Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol|
J Volavka, P Czobor, TB Cooper, B Sheitman, JP Lindenmayer, L Citrome, ...
Journal of Clinical Psychiatry 65 (1), 57-61, 2004
|When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed|
L Citrome, TA Ketter
International journal of clinical practice 67 (5), 407-411, 2013
|Compelling or irrelevant? Using number needed to treat can help decide|
Acta Psychiatrica Scandinavica 117 (6), 412-419, 2008
|Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients|
L Citrome, A Jaffe, J Levine, B Allingham, J Robinson
Psychiatric Services 55 (9), 1006-1013, 2004
|Do guidelines for severe mental illness promote physical health and well-being?|
L Citrome, D Yeomans
Journal of Psychopharmacology 19 (6_suppl), 102-109, 2005